Eureka Home »
Welcome to Eureka, an online community for scientists to explore, connect and share big ideas.
With flu season approaching, it’s worth noting that the annual ounce of prevention we all should be rolling up our sleeves for, began with SPF chicken embryos for influenza vaccine seed production.
The ice bucket challenge heard round the world has helped raise awareness and over US$110 million (by last count) for amyotrophic lateral sclerosis (ALS) research. The bigger challenge will be finding more effective treatments, a cure or a way to prevent this complex neurodegenerative disorder.
Two new reports from the CDC and the WHO offer sobering forecasts on the escalating Ebola crisis in West Africa.
The significance of the microbiome and early immune education in securing a healthier and more balanced life is explored in depth in the 60-minute documentary “Microbirth,” released in theatres Sept. 20-21.
With the pharmaceutical sector more reticent about drug discovery, disease foundations are increasingly driving the science, and in the quest for novel treatments, cures and vaccines they are turning more to CROs
Regulatory requirements for preclinical safety and efficacy studies of cellular therapeutic agents tend to be more fluid than those for standard toxicology studies. Here are five tips that can help make the process more efficient.
A Huffington Post commentary about the escalating Ebola crisis in West Africa notes the full extent of the outbreak’s damage will be hard to measure. Unlike the fairly precise death data being collected and reported on Ebola, data on other diseases – from malaria to diarrheal disease and tuberculosis—are outdated and imprecise.
Could our own immune system be cancer’s undoing? New therapies that harness the immune system are beginning to make their way to the clinic, with many more in the pipeline.
Novel therapies are helping reduce the rate of cardiovascular diseases related to diabetes, but there is a need to de-risk these agents before they reach the clinic. The Diabetes Complications Consortium, set up to share data on phenotypic mouse models, is trying to help researchers meet that goal.
Renegade macrophages—the garbage collectors of the immune system—go rogue in obesity and Type 2 Diabetes. The third in a series on diabetes complications.